Sakar Healthcare

64
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE732S01012
  • NSEID: SAKAR
  • BSEID:
INR
412.95
-7.05 (-1.68%)
BSENSE

Dec 18

BSE+NSE Vol: 20808

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
Operating Income
153.00
133.00
128.00
94.00
82.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
Net Sales
153.00
133.00
128.00
94.00
82.00
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
85.00
73.00
73.00
52.00
42.00
Power & Fuel Cost
3.00
2.00
2.00
2.00
3.00
Employee Cost
19.00
16.00
15.00
13.00
12.00
Operating Expenses
0.00
0.00
1.00
0.00
0.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1.00
2.00
2.00
1.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
114.00
100.00
98.00
72.00
63.00
Operating Profit (PBDIT) excl Other Income
38.00
33.00
29.00
22.00
19.00
Other Income
3.00
4.00
2.00
1.00
2.00
Operating Profit (PBDIT)
41.00
37.00
31.00
23.00
21.00
Interest
7.00
5.00
2.00
2.00
2.00
Profit before Depriciation and Tax
33.00
31.00
28.00
21.00
19.00
Depreciation
18.00
14.00
9.00
8.00
7.00
Profit Before Taxation & Exceptional Items
15.00
16.00
18.00
13.00
12.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
15.00
16.00
18.00
13.00
12.00
Provision for Tax
4.00
4.00
3.00
2.00
2.00
Profit After Tax
11.00
12.00
15.00
10.00
9.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
68.00
56.00
40.00
31.00
21.00
Profit Available for appropriations
80.00
68.00
56.00
41.00
31.00
Appropriations
80.00
68.00
56.00
41.00
31.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
5.63
6.75
8.73
6.87
6.40
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 15.80% vs 14.99% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 29.51% vs 15.75% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 12.44% vs 27.58% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 49.96% vs -8.53% in Mar 2024

Compare Profit and Loss Results of Sakar Healthcare
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
153.00
623.00
-470.00
-75.44%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
153.00
623.00
-470.00
-75.44%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
8.00
-9.00
-112.50%
Raw Materials Consumed
85.00
282.00
-197.00
-69.86%
Power & Fuel Cost
3.00
11.00
-8.00
-72.73%
Employee Cost
19.00
112.00
-93.00
-83.04%
Operating Expenses
0.00
27.00
-27.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
28.00
-27.00
-96.43%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
3.00
-3.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
114.00
521.00
-407.00
-78.12%
Operating Profit (PBDIT) excl Other Income
38.00
101.00
-63.00
-62.38%
Other Income
3.00
22.00
-19.00
-86.36%
Operating Profit (PBDIT)
41.00
123.00
-82.00
-66.67%
Interest
7.00
1.00
6.00
600.00%
Profit before Depriciation and Tax
33.00
122.00
-89.00
-72.95%
Depreciation
18.00
12.00
6.00
50.00%
Profit Before Taxation & Exceptional Items
15.00
109.00
-94.00
-86.24%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
15.00
109.00
-94.00
-86.24%
Provision for Tax
4.00
26.00
-22.00
-84.62%
Profit After Tax
11.00
82.00
-71.00
-86.59%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
68.00
507.00
-439.00
-86.59%
Profit Available for appropriations
80.00
589.00
-509.00
-86.42%
Appropriations
80.00
589.00
-509.00
-86.42%
Equity Dividend (%)
0%
18%
-18.00
Earnings Per Share
5.63
41.11
-35.48
-86.31%
Profit And Loss - Net Sales
Net Sales 177.58 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.80% vs 14.99% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 49.68 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 29.51% vs 15.75% in Mar 2024

Profit And Loss - Interest
Interest 8.54 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 12.44% vs 27.58% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 17.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 49.96% vs -8.53% in Mar 2024